The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...

Life expectancy in the United States increased in 2023, reaching 78.4 years, while drug overdose mortality decreased from ...

Light-to-moderate consumption of wine, measured through an objective urinary biomarker, is associated with lower CVD risk in ...